Ceftriaxone reduces <scp>L</scp>‐dopa–induced dyskinesia severity in 6‐hydroxydopamine parkinson's disease model

Abstract

Initiation of ceftriaxone after nigrostriatal lesion, but prior to and during l-dopa, may reduce dyskinesia severity without affecting l-dopa efficacy or the reduction of striatal tyrosine hydroxylase loss. © 2017 International Parkinson and Movement Disorder Society.